OxThera AB
556681-5667ActiveDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
Översikt
- 0
- Anställda
- ≤1t SEK
- Omsättning
- 2005
- Grundat
Nyckelbeslutsfattare
Jonas Brambeck
Deputy Director of the Board
John Goldie
Chairman
Mats-Olof Wallin
Chief Financial Officer
Elisabeth Lindner
Chief Operating Officer
Beskrivning
OxThera AB is a privately-held biopharmaceutical company dedicated to developing novel treatment options for rare kidney diseases, primarily Primary Hyperoxaluria (PH). Their core mission is to improve the quality of life and extend the life expectancy of patients suffering from this devastating ult...
Taggar
Nyckelord
Teknikstack
Företagsinformation
- Bransch
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Juridisk form
- Aktiebolag
- Momsnummer
- SE556681566701
Beslutsfattare
4 kontakter i FunnelfeedrJonas Brambeck
Deputy Director of the Board
John Goldie
Chairman
Mats-Olof Wallin
Chief Financial Officer
Elisabeth Lindner
Chief Operating Officer
Liknande företag
20 liknande företag i FunnelfeedrULTRAGENYX EUROPE GMBH
1–4 anställdaAdvancing transformative medicines for rare and ultra-rare genetic diseases globally.
BioGaia Pharma AB
0 anställdaDeveloping and out-licensing novel biotherapeutic platforms from microbiome research.
Sixera Pharma AB
1–4 anställdaSmall biotech developing first treatment for rare Netherton syndrome.
Calliditas Therapeutics AB
20–49 anställdaPioneering novel treatments for rare renal and hepatic diseases globally.
BridgeBio International GmbH
1–4 anställdaDeveloping transformative medicines for rare genetic conditions quickly.
Utforska mer
Frågor om OxThera AB
Vill du se Funnelfeedr i praktiken?
Boka en gratis demo och upptäck hur Funnelfeedr hjälper dig att hitta och konvertera dina idealkunder.
Boka en demo